Sorting of Circulating Tumor Cells/Extracellular Vesicles Using Microfluidics

A special issue of Micromachines (ISSN 2072-666X).

Deadline for manuscript submissions: closed (30 April 2022) | Viewed by 369

Special Issue Editors


E-Mail Website
Guest Editor
Leslie Dean Faculty of Pharmacy, University of Toronto, Toronto, ON M5S, Canada
Interests: microfluidics and BioMEMS; circulating tumor cell isolation; magnetic-based cell sorting; magnetic-based nanoparticle sorting; simulation and fabrication of microfluidic-based biomedical devices; exosomes

E-Mail Website
Guest Editor
Institute of Bioscience, UNESP, Botucatu 18618-000, SP, Brazil
Interests: biosensors; electroanalytical; diagnostics
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear colleagues,

Precision medicine has been a popular subject featuring personalized therapy development. Unlike traditional therapies which may rely on a one-drug-fits-all model, more newly developed technologies such as molecular diagnostics, systems biology, are applied in precision medicine to classify individuals into subpopulations so that more specific treatments can be implemented. An important application of precision medicine is in cancer treatment. The development of methods for the non-invasive detection of biomarkers could lead to new screening tests for early diagnosis of cancers. However, the detection and isolation of biomarkers such as circulating tumor cells (CTCs), extracellular vesicles, are technically challenging. Microfluidics is widely studied as a next-generation technology for new biomarker sorting, analysis, and clinical application in cancer treatment, for the fact that it provides methods for the handling of biological samples at micro/nano scale with high precision. As such, microfluidic technologies like CTC isolation chips have been proved to be important supplements for cancer diagnosis, prognosis, and therapeutics.  Accordingly, this Special Issue seeks to show case research papers and review articles that focus on: (1) novel designs, fabrication, control, and modeling of microfluidic devices for circulating tumor cell sorting, isolation, detection and analysis; and (2) new developments of microfluidic technologies for extracellular vesicle sorting and clinical application.

Dr. Kangfu Chen
Prof. Dr. Valber de Albuquerque Pedrosa
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Micromachines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Microfluidics
  • circulating tumor cells
  • extracellular vesicles
  • fabrication
  • modeling
  • clinical application

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop